Clin2
NCT07079657Possibly a fitRecruiting

Thulium laser and growth factors for hair loss

Androgenetic Alopecia (AGA)

Part of Skin clinical trials.

This trial tests whether a special laser combined with growth factor injections can help regrow hair in people with common hereditary hair loss (androgenetic alopecia). It aims to find a new treatment option that may work better than current methods.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been diagnosed with hereditary hair loss (androgenetic alopecia)
  • You are in overall good health without serious medical conditions
  • You are not pregnant or breastfeeding
  • You are willing to come in for all study visits
  • You have not used certain medications (like isotretinoin) or had recent laser treatments on your scalp

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07327359Recruiting· Phase 1/Phase 2
Hair loss treatment for men with male pattern baldness

This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.

Botany, New South Wales
NCT07370519Recruiting· Phase 2
Probiotic lotion for hair loss

This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.

Shenzhen, Guangdong
NCT07693244Recruiting· Phase 2
Exosome therapy for male pattern baldness

This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.

Beijing
NCT07536100Recruiting
New Hair Growth Serum vs. Minoxidil for Hair Loss

This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.

Bangkok, Bangkok
NCT06622824Not yet recruiting· Phase 2/Phase 3
Study of a new scalp solution for male hair loss

This study tests a new scalp solution (KX-826) for men with androgenetic alopecia, commonly known as male pattern baldness. It aims to see if the solution can help regrow hair and is safe to use. Participants will apply the solution to their scalp and have their hair growth monitored over time.

Beijing
NCT06946550Recruiting
Laser treatment for scarring hair loss with gene study

This trial tests if a non-ablative laser can help treat scarring alopecia (a type of hair loss where follicles are replaced by scar tissue). Researchers will also study your hair follicles' genes to understand how the laser works. It may be an option if your hair loss has been stable for at least 3 months.

Elmsford, New York

Hear when a new Androgenetic Alopecia (AGA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.